Aminoglycoside drugs in clinical practice: an evidence-based approach.
about
In vitro Pharmacokinetics/Pharmacodynamics Evaluation of Fosfomycin Combined with Amikacin or Colistin against KPC2-Producing Klebsiella pneumoniae.Stable susceptibility to aminoglycosides in an age of low level, institutional use.Influence of empiric therapy with a beta-lactam alone or combined with an aminoglycoside on prognosis of bacteremia due to gram-negative microorganisms.Propensity-based study of aminoglycoside nephrotoxicity in patients with severe sepsis or septic shockInfluence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia.Amikacin therapy for urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosidesAcute infective endocarditisImpact of a high loading dose of amikacin in patients with severe sepsis or septic shock.Antimicrobial resistance of aerobes and facultative anaerobes isolated from the oral cavity.Current management of bloodstream infections.Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Aminoglycoside therapy in infectious diseases.High Rate of Multidrug-Resistant Gram-Negative Bacilli Carriage and Infection in Hospitalized Returning Travelers: A Cross-Sectional Cohort Study.Potency of parenteral antimicrobials including ceftolozane/tazobactam against nosocomial respiratory tract pathogens: considerations for empiric and directed therapy.Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.New plasmid-mediated aminoglycoside 6'-N-acetyltransferase, AAC(6')-Ian, and ESBL, TLA-3, from a Serratia marcescens clinical isolate.The efficacy of non-carbapenem antibiotics for the treatment of community-onset acute pyelonephritis due to extended-spectrum β-lactamase-producing Escherichia coli.Kidneys in chronic liver diseases.The challenge of curbing aminoglycoside resistance: can antimicrobial stewardship programs play a critical role?Efficacy and Safety of Plazomicin Compared with Levofloxacin in the Treatment of Complicated Urinary Tract Infection and Acute Pyelonephritis: A Multicenter, Randomized, Double-Blind, Phase 2 Study.Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients.High-dose amikacin for achieving serum target levels in critically ill elderly patients.Impact of combination therapy with aminoglycosides on the outcome of ICU-acquired bacteraemias
P2860
Q33804813-B91DFE0C-EAF1-4039-AE4E-EB0376B559D9Q33939064-65011B92-47CF-4965-A5E4-6D47A65AECC3Q34108527-190111CC-6957-47BD-BD36-8EDA23E161DEQ34597640-49A10D0B-9273-41DE-8391-95D721F1EBDCQ36172460-6D35B779-1D47-4FC6-AD9F-0B9509F5E099Q36461121-3056D545-E9F1-4465-B3F5-5B6301E625E9Q36726249-94889D64-7E59-4BA0-B158-DF6BC0C2CD16Q37305018-AF1BD492-EAAC-43C4-93ED-71527AF3E995Q37389435-65775EB2-E909-44BF-B02C-2A5D330F26E3Q37437466-67727DC9-223F-4B75-9865-CB39BA1EC626Q37768418-BD2E0E95-90AD-44E9-A696-2FE2F312888FQ38070006-A1C1B636-8EA7-44E2-AD89-05709C3AC6D0Q38090988-70344197-E806-4FFA-8B31-AAD2C06D7B35Q38112810-704A5B5D-8C31-414E-BD58-6692753DD55FQ38994294-AFC6F0C5-9B56-41B3-AF79-9092341C8333Q40330973-D3FE8170-64DD-47BE-A8A8-1A5BA6CCD9D7Q41091116-27FC7EC5-5B04-4BC9-B4C9-65F19E71AF50Q41552003-0E4F62DC-E8C5-47B6-9821-C39E41ACB5B0Q42210504-F42C870C-E55F-4C0A-84FA-D63B53B92C7DQ43209206-5846DEDF-0FAA-4EB5-AD50-6D5B5E74C5C8Q47939381-F2B45048-6570-4BF5-A906-CD80475A1C0DQ49598865-E2445FA5-43AE-4D72-9C3B-618B2FAB66F7Q49894608-1B3BFFEA-0BF1-4221-862C-984FA1B03386Q50319655-A7A922B9-FAD5-4C41-8CFF-D275D3815518Q57554413-2B01814D-35FE-4B38-B61C-354A92B0EC3A
P2860
Aminoglycoside drugs in clinical practice: an evidence-based approach.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Aminoglycoside drugs in clinical practice: an evidence-based approach.
@en
Aminoglycoside drugs in clinical practice: an evidence-based approach.
@nl
type
label
Aminoglycoside drugs in clinical practice: an evidence-based approach.
@en
Aminoglycoside drugs in clinical practice: an evidence-based approach.
@nl
prefLabel
Aminoglycoside drugs in clinical practice: an evidence-based approach.
@en
Aminoglycoside drugs in clinical practice: an evidence-based approach.
@nl
P2860
P356
P1476
Aminoglycoside drugs in clinical practice: an evidence-based approach.
@en
P2093
Liat Vidal
P2860
P304
P356
10.1093/JAC/DKN469
P407
P577
2008-11-19T00:00:00Z